Showing results (1-10 of 232) with videos related to
Sort By:
Pageof 24
Discovery Medicine|August 14, 2010
Positron emission tomography (PET) and anticancer drug developmentCatharine M L West, Terry Jones, Pat PriceThe Lancet. Oncology|March 3, 2012
Development and experimental medicine applications of PET in oncology: a historical perspectiveTerry Jones, Pat PriceClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancersPaula Wells, Terry Jones, Pat PriceBiochimica Et Biophysica Acta|December 14, 2004
Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidinePaula Wells, Catharine West, Terry Jones, et al.British Journal of Cancer|February 10, 2022
Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancerCatharine M L WestCurrent Opinion in Supportive and Palliative Care|March 6, 2009
Measurement tools for gastrointestinal symptoms in radiation oncologyCatharine M L West, Susan E DavidsonScience Translational Medicine|March 17, 2017
Total-body imaging: Transforming the role of positron emission tomographySimon R Cherry, Ramsey D Badawi, Joel S Karp, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
2-[11C]thymidine positron emission tomography reproducibility in humansPaula Wells, Roger N Gunn, Colin Steel, et al.Nature Reviews. Clinical Oncology|December 8, 2022
Predicting tumour radiosensitivity to deliver precision radiotherapyJames M Price, Asmithaa Prabhakaran, Catharine M L WestPageof 24